Haining; William N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Haining; William N..The latest application filed is for "modulating ptpn2 to increase immune responses and perturbing gene expression in hematopoietic stem cell lineages".

Company Profile

8.3.12

Haining; William N. - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulating Ptpn2 To Increase Immune Responses And Perturbing Gene Expression In Hematopoietic Stem Cell Lineages App 20220081691 - Haining; William N. ; et al.	2022-03-17
Modulating Biomarkers Such As Spp To Increase Tumor Immunity And Improve The Efficacy Of Cancer Immunotherapy App 20220057403 - Haining; William N. ; et al.	2022-02-24
In vivo methods for identifying cancer-associated immunotherapy targets Grant 11,179,480 - Haining , et al. November 23, 2	2021-11-23
T-cell Exhaustion State-specific Gene Expression Regulators And Uses Thereof App 20210309965 - Haining; William N. ; et al.	2021-10-07
Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators Grant 10,927,410 - Haining , et al. February 23, 2	2021-02-23
MODULATING dsRNA EDITING, SENSING, AND METABOLISM TO INCREASE TUMOR IMMUNITY AND IMPROVE THE EFFICACY OF CANCER IMMUNOTHERAPY AND/OR MODULATORS OF INTRATUMORAL INTERFERON App 20200377879 - Meyerson; Matthew ; et al.	2020-12-03
Modulating Biomarkers To Increase Tumor Immunity And Improve The Efficacy Of Cancer Immunotherapy App 20200300857 - Haining; William N. ; et al.	2020-09-24
Modulating Biomarkers To Increase Tumor Immunity And Improve The Efficacy Of Cancer Immunotherapy App 20200300859 - Haining; William N. ; et al.	2020-09-24
Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo Grant 10,653,123 - Haining , et al.	2020-05-19
Modulating Biomarkers To Increase Tumor Immunity And Improve The Efficacy Of Cancer Immunotherapy App 20200149042 - Haining; William N. ; et al.	2020-05-14
In Vivo Methods For Identifying Cancer-associated Immunotherapy Targets App 20170360963 - Haining; William N. ; et al.	2017-12-21
Compositions And Methods For Identification, Assessment, Prevention, And Treatment Of T-cell Exhaustion Using Cd39 Biomarkers And Modulators App 20170233808 - Haining; William N. ; et al.	2017-08-17
Methods and Compositions for Perturbing Gene Expression in Hematopoietic Stem Cell Lineages In Vivo App 20170215392 - Haining; William N. ; et al.	2017-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.